Manulife (Manufacturers Life Insurance)
SYRS

Manulife (Manufacturers Life Insurance)’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,579
Closed -$117 – 3204
2021
Q4 		$117 Buy
3,579
+154
+4% +$6.24K ﹤0.01% 3035
2021
Q3 		$153K Sell
3,425
-228
-6% -$11.1K ﹤0.01% 3062
2021
Q2 		$199K Buy
3,653
+812
+29% +$48.1K ﹤0.01% 3108
2021
Q1 		$212K Buy
2,841
+233
+9% +$24.2K ﹤0.01% 2851
2020
Q4 		$283K Buy
2,608
+82
+3% +$7.48K ﹤0.01% 2554
2020
Q3 		$223K Hold
2,526
– – ﹤0.01% 2499
2020
Q2 		$266K Buy
2,526
+209
+9% +$18.8K ﹤0.01% 2333
2020
Q1 		$137K Buy
2,317
+163
+8% +$11.1K ﹤0.01% 2478
2019
Q4 		$149K Sell
2,154
-108
-5% -$6.55K ﹤0.01% 2692
2019
Q3 		$236K Sell
2,262
-104
-4% -$9.82K ﹤0.01% 2468
2019
Q2 		$219K Buy
2,366
+1,347
+132% +$93.8K ﹤0.01% 2584
2019
Q1 		$93K Buy
+1,019
New +$71K ﹤0.01% 2585
2018
Q4 		– Sell
-1,036
Closed -$123K – 2861
2018
Q3 		$123K Sell
1,036
-1,007
-49% -$117K ﹤0.01% 2877
2018
Q2 		$208K Buy
2,043
+751
+58% +$93K ﹤0.01% 3106
2018
Q1 		$168K Buy
1,292
+969
+300% +$106K ﹤0.01% 3143
2017
Q4 		$32K Sell
323
-364
-53% -$48.9K ﹤0.01% 3666
2017
Q3 		$101K Sell
687
-369
-35% -$69.4K ﹤0.01% 3323
2017
Q2 		$170K Buy
1,056
+1,047
+11,633% +$164K ﹤0.01% 3143
2017
Q1 		$1K Hold
9
– – ﹤0.01% 4099
2016
Q4 		$1K Buy
+9
New +$1.26K ﹤0.01% 4247

Other funds holding SYRS

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s SYRS Position: Q1 2022 in Review

Manulife (Manufacturers Life Insurance) sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q1 2022, closing a stake of 3,579 shares — an estimated $117 sold.

Manulife (Manufacturers Life Insurance) first reported a position in SYRS in Q4 2016 and held it in 20 quarters. The position peaked at $283K in Q4 2020. 94 funds tracked by Wall St. Rank hold SYRS as of Q1 2022.

  • Manulife (Manufacturers Life Insurance) reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 3,579 Syros Pharmaceuticals, Inc. Common Stock shares in Q1 2022, an estimated $117.
  • Manulife (Manufacturers Life Insurance) first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q4 2016 and held it in 20 quarters.
  • Manulife (Manufacturers Life Insurance)'s Syros Pharmaceuticals, Inc. Common Stock position peaked at $283K in Q4 2020.
  • 94 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q1 2022.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2022, filed 20 May 2022.